NIVOLUMAB AND HYALURONIDASE-NVHY

NIVOLUMAB AND HYALURONIDASE-NVHY was reported 136 times

These side effects are most commonly reported by patients taking NIVOLUMAB AND HYALURONIDASE-NVHY:

# Side effect Count
0 OFF LABEL USE 35
1 FATIGUE 12
2 RASH 12
3 PRODUCT STORAGE ERROR 11
4 ARTHRALGIA 10
5 DEATH 8
6 DIARRHOEA 7
7 CONSTIPATION 6
8 DECREASED APPETITE 6
9 PRODUCT DOSE OMISSION ISSUE 6
10 NAUSEA 5
11 PRODUCT STORAGE ISSUE 5
12 DIZZINESS 4
13 MALIGNANT NEOPLASM PROGRESSION 4
14 MYALGIA 4
15 PAIN IN EXTREMITY 4
16 PRURITUS 4
17 WEIGHT DECREASED 4
18 ADVERSE EVENT 3
19 DRY SKIN 3
20 HYPERHIDROSIS 3
21 MALAISE 3
22 PNEUMONITIS 3
23 SEIZURE 3
24 URTICARIA 3
25 ADRENAL INSUFFICIENCY 2
26 ASTHENIA 2
27 DIPLOPIA 2
28 DISCOMFORT 2
29 DRY MOUTH 2
30 DYSPHONIA 2
31 DYSPNOEA EXERTIONAL 2
32 FULL BLOOD COUNT DECREASED 2
33 HOSPITALISATION 2
34 ILLNESS 2
35 IMPAIRED HEALING 2
36 INJECTION SITE BRUISING 2
37 INJECTION SITE ERYTHEMA 2
38 LABORATORY TEST ABNORMAL 2
39 PAIN 2
40 PERIPHERAL SWELLING 2
41 PRODUCT PREPARATION ISSUE 2
42 SKIN EXFOLIATION 2
43 SKIN LESION 2
44 VOMITING 2
45 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
46 ABDOMINAL DISCOMFORT 1
47 ABDOMINAL DISTENSION 1
48 ABDOMINAL PAIN 1
49 ABSCESS ORAL 1
50 ACUTE KIDNEY INJURY 1
51 ACUTE RESPIRATORY FAILURE 1
52 ADNEXA UTERI PAIN 1
53 ANAEMIA 1
54 BACK PAIN 1
55 BENIGN NEOPLASM 1
56 BLISTER 1
57 BLOOD UREA INCREASED 1
58 BONE PAIN 1
59 BRAIN INJURY 1
60 CARDIAC ARREST 1
61 CARDIAC DISORDER 1
62 CARDIAC FAILURE CONGESTIVE 1
63 CARDIOMEGALY 1
64 CELLULITIS 1
65 CHAPPED LIPS 1
66 CHILLS 1
67 COUGH 1
68 CRANIAL NERVE DISORDER 1
69 CRANIAL NERVE PARALYSIS 1
70 DECUBITUS ULCER 1
71 DEEP VEIN THROMBOSIS 1
72 DEHYDRATION 1
73 DEVICE USE ERROR 1
74 DRUG HYPERSENSITIVITY 1
75 DRUG INEFFECTIVE 1
76 DRUG INTOLERANCE 1
77 DRY EYE 1
78 DYSARTHRIA 1
79 DYSPNOEA 1
80 EOSINOPHILIA 1
81 EPISTAXIS 1
82 ERUCTATION 1
83 ERYTHEMA 1
84 EYE PRURITUS 1
85 EYELID PTOSIS 1
86 EYELID SKIN DRYNESS 1
87 FAECES SOFT 1
88 FEELING ABNORMAL 1
89 FOLLICULITIS 1
90 GAIT DISTURBANCE 1
91 GASTROINTESTINAL DISORDER 1
92 GASTROOESOPHAGEAL REFLUX DISEASE 1
93 GLOSSODYNIA 1
94 HAEMOGLOBIN DECREASED 1
95 HAEMORRHOIDS 1
96 HEADACHE 1
97 HEART RATE INCREASED 1
98 HEPATIC CIRRHOSIS 1
99 HEPATIC FAILURE 1
100 HICCUPS 1
101 HYPERTRANSAMINASAEMIA 1
102 HYPOAESTHESIA ORAL 1
103 HYPOCALCAEMIA 1
104 HYPOMAGNESAEMIA 1
105 HYPONATRAEMIA 1
106 IMMUNE-MEDIATED MYOCARDITIS 1
107 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
108 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
109 INFUSION SITE ERYTHEMA 1
110 INGROWN HAIR 1
111 INJECTION SITE HAEMORRHAGE 1
112 INJECTION SITE PAIN 1
113 INJECTION SITE RASH 1
114 INJECTION SITE SWELLING 1
115 INTERNAL JUGULAR VEIN STENOSIS 1
116 IRON DEFICIENCY ANAEMIA 1
117 LIP SWELLING 1
118 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
119 MEMORY IMPAIRMENT 1
120 MUSCULAR WEAKNESS 1
121 MUSCULOSKELETAL PAIN 1
122 MUSCULOSKELETAL STIFFNESS 1
123 MYOSITIS 1
124 NASOPHARYNGITIS 1
125 NIGHT SWEATS 1
126 NON-SMALL CELL LUNG CANCER 1
127 OCULAR HYPERAEMIA 1
128 ORAL DISCOMFORT 1
129 OROPHARYNGEAL PAIN 1
130 PAIN OF SKIN 1
131 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
132 PANCREATIC DISORDER 1
133 PANCREATIC FAILURE 1
134 PANCREATOGENOUS DIABETES 1
135 PARAESTHESIA ORAL 1
136 PLEURAL EFFUSION 1
137 POLYARTHRITIS 1
138 PORTAL HYPERTENSION 1
139 PRESYNCOPE 1
140 PRODUCT DISTRIBUTION ISSUE 1
141 PRODUCT PRESCRIBING ISSUE 1
142 PROTEIN TOTAL DECREASED 1
143 PULMONARY FIBROSIS 1
144 PYREXIA 1
145 RASH MACULAR 1
146 RASH MACULO-PAPULAR 1
147 RASH PRURITIC 1
148 RECTAL HAEMORRHAGE 1
149 RENAL FAILURE 1
150 RENAL IMPAIRMENT 1
151 RESTLESS LEGS SYNDROME 1
152 SCRATCH 1
153 SENSITIVE SKIN 1
154 SEPTIC SHOCK 1
155 SINUSITIS 1
156 SKIN ATROPHY 1
157 SKIN FISSURES 1
158 SKIN SWELLING 1
159 SLEEP DISORDER 1
160 SPINAL DISORDER 1
161 STOMATITIS 1
162 SWELLING FACE 1
163 SYNCOPE 1
164 TACHYCARDIA 1
165 THYROID FUNCTION TEST ABNORMAL 1
166 TONGUE BLISTERING 1
167 UNEVALUABLE EVENT 1
168 UNRESPONSIVE TO STIMULI 1
169 VASCULAR CALCIFICATION 1
170 VOCAL CORD PARALYSIS 1